Clinical Trial Update: Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating node-sparing radiotherapy combined with total neoadjuvant CAPOX chemotherapy and sintilimab for microsatellite-stable locally advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Jinhua Central Hospital | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: RECRUITING